(Q33446708)

English

FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation

scientific article

Statements

FDA review summary: Mozobil in combination with granulocyte colony-stimulating factor to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation (English)
Sarah Pope Miksinski

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit